Financhill
Sell
15

HCAT Quote, Financials, Valuation and Earnings

Last price:
$2.39
Seasonality move :
-18.48%
Day range:
$2.33 - $2.41
52-week range:
$2.02 - $7.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.51x
P/B ratio:
0.51x
Volume:
274.7K
Avg. volume:
751.7K
1-year change:
-65.51%
Market cap:
$168.3M
Revenue:
$306.6M
EPS (TTM):
-$1.58

Earnings Data

Next earnings date for HCAT
Feb 25
2026
Most recent earnings per share
-$0.32
Missed by $0.38
(Nov 10/2025)
Consensus Estimate
$0.07
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HCAT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $73.9M -- -- $0.10 --
11/10/2025 Q3 $75.1M $76.3M -$0.32 $0.07 -$0.38
08/07/2025 Q2 $80.6M $80.7M -$0.59 $0.04 -$0.63
05/07/2025 Q1 $79.2M $79.4M -$0.35 $0.00 -$0.35
02/26/2025 Q4 $79.6M $79.6M -$0.33 $0.08 -$0.41
11/06/2024 Q3 $76.4M $76.4M -$0.24 $0.09 -$0.33
08/07/2024 Q2 $75M $75.9M -$0.23 $0.08 -$0.31
05/09/2024 Q1 $74.8M $74.7M -$0.35 $0.03 -$0.38
02/22/2024 Q4 $73.6M $75.1M -$0.53 -$0.01 -$0.52
11/02/2023 Q3 -- -- -$0.39 -$0.01 -$0.38
08/08/2023 Q2 -- -- -$0.58 -$0.01 -$0.57
05/09/2023 Q1 -- -- -$0.60 -$0.04 -$0.56
02/28/2023 Q4 -- -- -$0.66 -$0.11 -$0.55
11/08/2022 Q3 -- -- -$0.84 -$0.19 -$0.65
08/04/2022 Q2 -- -- -$0.62 -$0.09 -$0.53
05/10/2022 Q1 -- -- -$0.54 -$0.11 -$0.43
03/01/2022 Q4 -- -- -$0.94 -$0.21 -$0.73
11/09/2021 Q3 -- -- -$0.82 -$0.22 -$0.60
08/05/2021 Q2 -- -- -$0.80 -$0.14 -$0.66
05/06/2021 Q1 -- -- -$0.65 -$0.14 -$0.51
02/25/2021 Q4 -- -- -$1.01 -$0.20 -$0.81
11/10/2020 Q3 -- -- -$0.68 -$0.27 -$0.41
08/11/2020 Q2 -- -- -$0.71 -$0.22 -$0.49
05/12/2020 Q1 -- -- -$0.47 -$0.26 -$0.21
02/27/2020 Q4 -- -- -$0.39 -$0.28 -$0.11
11/12/2019 Q3 -- -- -$1.40 -$0.37 -$1.03
08/22/2019 Q2 -- -- -$3.21 -$0.32 -$2.88
03/31/2019 Q1 -- -- -$2.80 -- --
12/31/2018 Q4 -- -- -$2.80 -- --
09/30/2018 Q3 -- -- -$0.63 -- --
06/30/2018 Q2 -- -- -$0.62 -- --
03/31/2018 Q1 -- -- -$0.06 -- --

Health Catalyst, Inc. Earnings Questions

  • How Much did Health Catalyst, Inc. Generate in Revenue Last Quarter?

    Health Catalyst, Inc. reported $76.3M worth of top line sales in its most recent quarter.

  • Did Health Catalyst, Inc. Beat Earnings Last Quarter?

    Health Catalyst, Inc. announced earnings per share of -$0.32 which represents a miss of analyst forecast a $0.07 per share.

  • Is Health Catalyst, Inc. Profitable?

    Health Catalyst, Inc. reported $26.3M that represents $0.37 per share over the last quarter.

  • What is the Analyst Consensus for Health Catalyst, Inc. EPS Next Year?

    Health Catalyst, Inc.'s earnings are forecast to decrease from -$1.15 per share to $0.31 per share next year representing a decrease of -99.87%.

  • When is Health Catalyst, Inc.'s Earnings Date?

    Health Catalyst, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock